Loading clinical trials...
Loading clinical trials...
The aim of study is to describe the clinical, immunological, serological, virological and therapeutic characteristics of HIV+ patients harboring isolated anti-HBc profile and to assess the response to...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ANRS, Emerging Infectious Diseases
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT06694805 · HIV Infections
NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT02932150 · Chronic Hepatitis B
Chu Dijon
Dijon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions